Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fastenal

42.46
+0.50001.19%
Post-market: 42.520.0600+0.14%19:53 EDT
Volume:7.02M
Turnover:297.27M
Market Cap:48.75B
PE:39.71
High:42.56
Open:41.90
Low:41.78
Close:41.96
52wk High:50.63
52wk Low:35.31
Shares:1.15B
Float Shares:1.14B
Volume Ratio:0.63
T/O Rate:0.61%
Dividend:0.85
Dividend Rate:2.00%
EPS(TTM):1.07
EPS(LYR):1.00
ROE:32.74%
ROA:20.50%
PB:12.52
PE(LYR):42.27

Loading ...

Fastenal’s Q3 Earnings Call Highlights Growth and Challenges

TIPRANKS
·
Oct 15

Serve Robotics Named to Fast Company’s Next Big Things in Tech List

GlobeNewswire
·
Oct 15

Fastenal price target lowered to $48 from $49 at BofA

TIPRANKS
·
Oct 15

BUZZ-U.S. STOCKS ON THE MOVE-Spyre Therapeutics, Astria, Walmart

Reuters
·
Oct 15

Fastenal Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Oct 14

Labor Market Could Change Fast, JPMorgan CFO Warns -- WSJ

Dow Jones
·
Oct 14

BUZZ-Barclays cuts Fastenal PT after Q3 profit miss estimates

Reuters
·
Oct 14

SMH ETF News: Fast Daily Recap – 10/14/25

TIPRANKS
·
Oct 14

Check Point Recognized on Fast Company’s 2025 “Next Big Things in Tech” List for Securing Public Blockchain

GlobeNewswire
·
Oct 14

Morgan Stanley Reaffirms Their Hold Rating on Fastenal Company (FAST)

TIPRANKS
·
Oct 14

Baird Adjusts Price Target on Fastenal to $49 From $53, Maintains Outperform Rating

MT Newswires Live
·
Oct 14

What Bristol-Myers Squibb (BMY)'s FDA Fast Track for Alzheimer’s Drug Means for Shareholders

Simply Wall St.
·
Oct 14

Fastenal Reports Strong Q3 2025 Financial Results

TIPRANKS
·
Oct 14

How Investors Are Reacting To Nektar Therapeutics (NKTR) Securing FDA Fast Track For Eczema Drug Candidate

Simply Wall St.
·
Oct 14

Fastenal Co. Stock Slips 7.6%, Underperforms Peers

Dow Jones
·
Oct 14

Recent Dividend Declarations

Dow Jones
·
Oct 14

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Reuters
·
Oct 14

Top Midday Decliners

MT Newswires Live
·
Oct 14

BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv

Reuters
·
Oct 14

Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge

Benzinga
·
Oct 14